3
Announcements
Trials
Browse
Landscape
Sponsor
Interventions
pembrolizumab
3
Pemetrexed
2
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
Carboplatin
2
trifluridine tipiracil drug combination
1
tislelizumab
1
sacituzumab govitecan
1
SYS6006 COVID-19 vaccine
1
Irinotecan
1
Drug Therapy
1
Docetaxel
1
Cetuximab
1
Bevacizumab
1
Antiemetics
1
ASP1570
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumors
×
ascrinvacumab
×
30 days
×
Clear all
No trials found.